chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient with sudden lack of weight bearing, limp to R leg, progressed to bilateral legs and lack of tone to central core.
PT EXP. 12 EPISODES OF VOMITING WITHIN .5 TO 1 HOUR AFTER FIRST DTP/OOPV IMMUN. RESOLVED SPONTANEOUSLY.
I had just seen my chiropractor for an adjustment, and let him know I was having issues with my left jaw and left arm. At my chiropractors recommendation I went to see my Cardiologist who referred me to the ER for testing. At the ER they did an X-Ray and CAT Scan where they discovered a nodule on my left lung, which was less than 1 cm. My PCP stated that he has seen this in patients who have had COVID-19, which I have not had at any point. I am under observation at this time, and will be having follow up CAT Scan in the fall. My lymph gland in my left breast area is still inflamed after beginning my COVID-19 vaccine series.
I have been feeling sick for about a week. On Nov 5th I called the doctors. They indicated that it was a sinus infection, and they gave me an antibiotic.  I'm doing better but I still have to take it for a week. doesn't believe it was related to the booster shot.
Case number PHHY2012US012947 is an initial literature report received on 14 Feb 2012. The authors published the adverse events following administration of H1N1 to pregnant women that were reported to Vaccine Adverse Event Reporting System (VAERS). This case refers to a female patient (age not specified). She was vaccinated with H1N1 (manufacturer and batch number: unknown) between 01 Oct 2009 to 28 Feb 2010. She was pregnant at the time of vaccination. On an unspecified date she had a cesarean section and she gave birth to a live neonate. Following caesarean the patient experienced uterine atony which led to hemorrhagic shock. The patient died due to hemorrhagic shock. The causality of the case was not reported. The authors stated that the VAERS database search did not reveal any clustering of spontaneous abortions, still births or congenital anomalies. Authors concluded that the pregnant women who were vaccinated with H1N1 inactivated and live vaccines did not show unusual pattern of maternal or fetal outcomes.
Headaches, vomiting, dizziness, loss of appetite, temperature, diarrhea, fatigue, blurred vision.
A red rash all over my body. It?s worse at the vaccine spot and gets better the further away
Cramping abdominal pain evening of injection with nausea, no vomiting, ate normal breakfast next day with normal BM when seen also had URI which had stated prior to shot.
This spontaneous report as received from a physician refers to a female patient of unknown age. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with GARDASIL 9 (strength, lot #, expiry date, dose, frequency, route of administration, anatomical location were unknown) for prophylaxis. On an unknown date, also reported as soon after the vaccination, the patient experienced shingles. The outcome of herpes zoster was unknown. The reporter's causality was unknown. No product quality complaint (PQC) was associated with this report.
States had a migraine for 1 day, swollen lymph notes to left axilla for 24 hrs.
Ovarian cyst rupture. Along with injection site pain reoccurring after healing. No previous cyst known.
Pt received DTaP vax in left upper thigh, developed surrounding redness/swelling. Seen 2/1/01 had mild redness 8cm surrounding injection site, mild swelling, no tenderness, no secondary cellulitis.
Symptoms began about 12 hours after the shot was administered.  They lasted for about 22 hours. I received the shot Friday morning, by Friday evening the symptoms had appeared and worsened throughout the night and day on Saturday. By late evening(6-8) I began feeling much better. The symptoms included body aches, high fever, chills, nausea, hallucinations, dehydration, dizziness, loss of appetite,  exhaustion, and a restless night of sleep.
Patient woke up not feeling well, slept all day Saturday, and went into cardiac arrest at 1:30  am on the morning of 10/30/22.  He was pronounced dead by emergency services at 2:30 am after an hour of CPR and resuscitation efforts.
No further AE; administration of an improperly stored vaccine; This spontaneous report as received from a Registered Nurse regarding  to a patient of unknown age and gender. Information regarding the patient's  concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On 15-JAN-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # T013537, expiration date 17-OCT-2021,  1 dosage form for prophylaxis.         The improperly stored suspect vaccine experienced a temperature of 9 degrees Celsius (°C) for 2 hours. There was no previous temperature excursion reported.  The call was made due to a digital data logger. No additional adverse effect reported.
This spontaneous report as received from a pharmacist refers to a patient of an unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On 18-JAN-2018, the patient was inadvertently vaccinated with an expired dose of ZOSTAVAX 19400 PFU, lot # M041086, expiration date 03-JAN-2018 (dose and route were not reported) for prophylaxis. No adverse events were reported.
Ptn came to Rx 12/4/15. Complaint of "achy" shoulder, arm, back. Recommend call MD.
severe swelling, hardening of area and redness at injection site; itching at site; headache; as of 08/18/2011 these symptoms still exist
Splotchy pink rash starting at left collarbone, covers left side of torso and left thigh; Rash is hot to the touch.; This is a spontaneous report from a non-contactable consumer (patient). A 25-year-old female patient received BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine), via an unspecified route of administration, administered in the left arm on 29Jul2021 at 10:15 AM (at the age of 25-years-old) (Batch/Lot Number: EW0177) dose number unknown, single, for COVID-19 immunization. Medical history included allergies to iodine and shellfish. The patient did not have COVID prior to the vaccination, was not pregnant, and did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications were not reported. On 29Jul2021 at 21:15, the patient experienced a splotchy pink rash starting at the left collarbone, which covered the left side of her torso and left thigh. There was no pain, itchiness, or discomfort. The rash was hot to the touch. The patient was not tested for COVID post vaccination. As treatment, the patient took 25mg of Benadryl. Outcome of the events was recovering.
3:45pm shot 9:00pm feeling a little tired and chilly 11:30am next day serious chills, tooks medicine and slept for 2 hours 1:30-2pm chills gone but felt fluish the rest of the day and evening 9:30pm had slight fever, more medicine then went to bed Wednesday morning pretty much felt back to normal
Patient received a Pfizer BioNTech Adolescent/Adult Vaccine (Lot# 301458A) that was stored in the regular freezer (-25 to  -15 oC) beyond 14 days. On 22JAN22 Pfizer responded to the Health Agency and Health Clinic that stability data does not support the use of the Pfizer Vaccine (Lot# 301458A). Pfizer further states decision to release or dispose of the product is the responsibility of Health Agency / Health Clinic. The CDC website states that if the manufacturer does not have the information to support the stability of the vaccine, repeat the dose immediately with no minimum interval.
Information was received from a pharmacist concerning a 62 year old female patient. On 12-NOV-2014, the patient was vaccinated with a single dose (unspecified amount) of ZOSTAVAX (lot # K009199, expiration date 27-SEP-2015), subcutaneously in the left arm. On 14-NOV-2014, the patient developed a 3-4 inch painful area of redness and warmth at the injection site and went to the pharmacy. The pharmacist suggested the patient apply cool compresses to the area of reaction and to take ibuprofen as needed for pain. The pharmacist requested a lot check. The outcome of developed 3-4 inch painful area of redness and warmth at the injection site was reported as recovering. This is one of 2 reports for this reporter. Additional information has been requested.
some bumps in forehead; fever; chills; knee pain; very bad headache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MASS (some bumps in forehead), PYREXIA (fever), CHILLS (chills), ARTHRALGIA (knee pain) and HEADACHE (very bad headache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 011L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN, ATORVASTATIN CALCIUM (LIPITOR) and LISINOPRIL for an unknown indication.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced MASS (some bumps in forehead), PYREXIA (fever), CHILLS (chills), ARTHRALGIA (knee pain) and HEADACHE (very bad headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MASS (some bumps in forehead), PYREXIA (fever), CHILLS (chills), ARTHRALGIA (knee pain) and HEADACHE (very bad headache) outcome was unknown.            This case was linked to MOD-2021-034348 (Patient Link).
Upon receiving injection, the RN administering noted that pt appeared anxious.  Following her 15 minute wait, EMT noted that as she stood up she commented to another pt that her throat felt "scratchy" after he made the same comment.  This patient was a volunteer at the vaccination site, and returned to her assignment.  Throughout the assignment, she began rubbing her chest and the injection site.  She returned to the EMTs approximately 2 hrs after receiving the vaccine to report  "feeling different".  EMTs witnessed redness on her chest area.  They administered Benedryl and Decadron IV, called 911.  All vitals WNL.  This writer called pt the following day, she reported having been transported to Hospital.  Bloodwork was obtained, she noticed while at hospital that the arm below where injected was covered in a "scarlatina type" rash.  This rash continues to persist, no additional symptoms reported. She was discharged from ER with  Rx for Pepcid and Prednisone and told to f/u with primary.  She saw the PA at her MDs office, and was told to f/u with an allergist.  She intends to go to Medical Center Allergy Immunology for f/u and further advice on receiving second dose of vaccine.  She will follow up with this writer regarding the scheduling/canceling of the second dose based on the consultation with the Allergist/Immunologist.
Narrative: COVID infection following COVID vaccine series 02/18, Pfizer, dose #1 03/10, Pfizer, dose #2 08/11 pt cd: cough, sore throat, fatigue, myalgias, rhinorrhea, nasal congestion, diarrhea, fever headache exposure: unknown 08/12 - 08/20 pt symptoms continue 08/12 COVID swab, result: detected 08/21 clinically resolved
Client states she developed a generalized rash (hands, wrists, knees, stomach, groin, neck, face) on the 7th day after her first dose of the Pfizer vaccine - itchy/some of the rash blistered - saw an MD who diagnosed it as a herpes infection - saw her usual provider who diagnosed it as an allergic reaction rash - prescribed antibiotics and prednisone - some of the rash remains and is itchy but no longer blistered.
Pt recvd 1 dose of Engerix-B & pt's sclera turned yellow; cleared p/2 days;
Took paxlovid as they had COVID-19 even though they have the 2 vaccines and a booster from Pfizer; Took paxlovid as they had COVID-19 even though they have the 2 vaccines and a booster from Pfizer; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Took paxlovid as they had COVID-19 even though they have the 2 vaccines and a booster from Pfizer". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: The patient and her husband took Paxlovid as they had COVID-19 even though they have the 2 vaccines and a booster from Pfizer.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300038590 same reporter/product/event, different patients;
Local site pain immediately; headache; chills; fatigue; general body aches; BNT162B2 , 17Dec2020 Dose number 1, 05Jan2020 Dose number 2; Pregnant at the time of vaccination?: Yes/received BNT162B2; Pregnant at the time of vaccination?: Yes/Pregnant at the time of vaccination?: Yes/received BNT162B2; Pregnant at the time of vaccination?: Yes; This is a spontaneous report from a contactable nurse. This is the mother report. A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: El0140), intramuscular on 17Dec2020 18:30 (dose number 1, right arm) and on 05Jan2021 18:30 (dose number 2, right arm) at single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included an unspecified prenatal drug, sertraline hydrochloride (ZOLOFT), and acetylcarnitine hydrochloride (NEUROTIN). The patient was pregnant at the time of vaccination. No other vaccines in four weeks was taken. Patient has no COVID-19 prior vaccination. Patient was not tested for COVID-19 post vaccination. The patient experienced Local site pain immediately, headache, chills, fatigue and general body aches next day on 06Jan2021. 09:00. No treatment was given. Event outcome was recovering. The reporter assessed the events as non-serious.
Pt. stated she could not move her arms about 24 hours post injection ; stated they were red and tender to the touch. She went to urgent care and they said she had an infection , presumably cellulitis .
Systemic: Fainting / Unresponsive-Mild, Additional Details: mom said she passes out after shots, fainted less than 1 min, had her lay down with feet up for 15 min, then sit up for 15min before leaving,
sore arm, t100.9  ax, 5-6cm tender from area @ site of shot
A few hours after vaccine , tendon in left foot started flaring causing pain. 5 hours after, severe pain, cannot even walk , pain while sedentary , feels like a broken foot so much pain in tendons .
Slight numbness of the left side of the body including face. Visited primary doctor on 1/25/21 and was referred to a Neurologist that I have an appointment on February 1, 2021. And went through MRI testing on 1/25/21.
This spontaneous report was received from a Licensed Practical Nurse referring to multiple patients of unknown age and gender. Patients' pertinent medical history, drug reaction/allergies or concomitant information were not reported. On unspecified dates, the patients were vaccinated with a dose of improperly stored PROQUAD subcutaneously, lot # M022400, expiration date: 01-NOV-2017 (strength and dose  were not provided) for prophylaxis. No adverse effects were reported. This is one of two reports received from the same reporter. Follow up information has been received on 12-DEC-2016 that all telephone attempts to obtain follow-up information had been unsuccessful. Additional information is not requested as no further information was available. Sender's Comments: US-009507513-1611USA000114: MERCK 1610USA011591: Mfr number.
pt did not have an adverse event. she received 1 shot of her primary series (pfizer monovalent) and received moderna bivalent booster on 10/06/22. According to the pt she did not complete the primary series. She did not report any adverse event.
Patient presented today for a 30 month check up. Patient's mom reports that a few hours after receiving vaccines at 11/07/2018 appt, she had a seizure. Mother states she did not take patient's temperature. She says she laid her in her bed and she started convulsing and was not responsive for about 3 minutes. She seemed fine after the seizure per mom. They did not seek any medical care or notify us of event at that time.
I reviewed patient questionnaire form- she is a regular patient - I am very familiar with her rx and medical profiles. Lahough she answered yes to the medical condition and allergy questions - I determined she was ok to get the shot bc she said the dr wanted her to get the Covid vaccination mid April to early May.  I took pat's temp it was 97.9 F.  when i asked all of the prescreening covid/immunization questions and asked her if she was feeling well she said yes and she also passed all of the covid screening questions.  I proceeded to give her the vaccine. 4:20pm administered Moderna Covid 19 vaccination, 4:25pm I checked on patient - patient looked lethargic and when asked how she felt - she was severely slurring her words I could hardly understand her- she said she felt dizzy, not good, nauseous, about to faint. I told her to remain seated and brought her water and asked her to check her blood glucose on her Freestyle Libre sensor arm unit - it read 60. I asked her if she wanted orange juice, she said yes and a hot dog- we immediately brought her both- she checked her BG again at 4:30 and it went down to 58... I asked her if she had taken any meds before the shot - she said she took 2 glucose, 1 morhphine sulfate 15mg tablet and 1 gabapentin 300mg capsule right before she walked into the pharmacy.  At 4:45 she felt nauseous and dizzy. She took another glucose tablet from her bag and she also asked me to inject her glucagon shot- I gave her glucagon shot in her thigh at 4:50. I told her to stay seated - me and my tech were closely watching her the entire time. at 5pm she said she had to vomit so we watched her get up and near the bathroom while she vomited.  she sat back down and took her BG level again it was going up at 115. We continued to monitor her thru 6:10pm when she said she was a lot better and since she wanted to leave - I made sure she answered my questions clearly and she did not slur. She left the pharmacy at 6:15
Body aches; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), CHILLS (Chills) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (Body aches), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, PAIN (Body aches), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Went to the ed on saturday about pain at the injection site.  They did an ultra sound and it was neg, some swelling was noted.  Was given meloxicam 15 mg, after calling md thursday.
Headache, severe joint and muscle pain, fatigue ongoing 99.3 - 100.6 degree fever for 3 days Nausea off and on for 3 days Took Tylenol when fever reached 100.6
Post vax, the pt developed an area of erythema and tenderness (about 6cm X 9cm) surrounding the injection site of right deltoid.
"Pfizer 1st dose 2/14/21 lot # EN6200, 2nd dose 3/7/21 lot # EN6198  Patient presented to HRH ED on 3/10/21 with bradycardic three days after receiving dose #2 of Pfizer COVID-19 vaccination at HRH vaccine clinic reporting abdominal pain, vomiting, and diarrhea. Admitted, increased PPI dose, underwent endoscopy, diagnosed with gastritis/gastroenteritis, and discharged to home the next day medically stable."
first dose given on 17 Sep 2018; second dose given on 26 Aug 2019; This case was reported by a physician via call center representative and described the occurrence of drug dose administration interval too long in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 17th September 2018).   On 29th August 2019, the patient received the 2nd dose of Shingrix. On 26th August 2019, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.    Additional Information: GSK Receipt Date: 05-Oct-2022 Reporter's comment: The physician stated a patient who received the second dose of Shingrix late wanted to repeat the series. No additional doses had been given as of the time of call. The permission was granted for safety to follow up. No additional information provided during the call. The consent to follow-up was granted. Additional Supportive Information: The patient received 2nd dose later than recommended time interval, which led to lengthening of vaccination schedules.
This spontaneous report was received from a healthcare worker (also reported as nurse) refers to a patient of unknown age and gender. Concurrent conditions, medical history and allergies were not reported. On 22-DEC-2014, the patient was vaccinated with a dose of M-M-R II, (strength, dose, route and anatomical location were not reported), (lot # J013316, expiration date: 22-OCT-2016), which was incorrect stored since 02-DEC-2014. No adverse effects were reported and no product quality complaint (PQC) was filled. This is one of several reports received from the same reporter. Additional information has been requested.
Employee stated that she woke up at midnight with severe nausea and started vomiting intermittently throughout the night.  She also experienced fever/chills/body aches and right arm pain.  Had to call in sick.
1/7/21 at 08:00 body chills and at 09:30 fever (Tmax 100.5 no meds taken), at time of call 11:00 temperature of 99.1
~3" irregular patch of erythema, lighter towards the center, on the left thigh around the area of the site the vaccines given. 2 small puncture wounds noted about 1cm apart. Small firm tender mass in area of puncture marks. Area of erythema not tender or warm to touch.
Long lasting pain in injection site starting several hours after shot and progressively has gotten worse over the last 4 months causing limited mobility of left arm.